Vitamin B12 Cancer Link Report
Analysis based on 12 articles · First reported May 18, 2026 · Last updated May 23, 2026
The research findings could influence consumer behavior regarding Vitamin B12 supplementation, potentially impacting sales for companies in the nutritional supplement industry. While not a direct market mover, it highlights the ongoing scrutiny of health products and the importance of evidence-based recommendations for public health.
A new report co-authored by Ahmed Elbediwy>>> and Nadine Wehida>>> from Queen s University at Kingston and published on The Conversation US>>> website, highlights a complex 'U-shaped' relationship between Vitamin B12 levels and cancer risk. The research suggests that both excessively high and insufficient levels of B12 may be associated with an increased risk of certain cancers, particularly colon cancer, as indicated by a 2025 case-control study from Vietnam>>>. While B12 is essential for cell function and DNA repair, the report cautions against 'megadosing' on supplements without medical advice, as high levels could theoretically support the growth of pre-cancerous cells. Elevated B12 levels are also identified as a potential marker for existing or progressing cancers, rather than a direct cause. The overall message emphasizes maintaining a balanced diet and avoiding unnecessary high-dose supplementation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard